JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB235455

OSMI-1, O-GlcNAc transferase (OGT) inhibitor

Be the first to review this product! Submit a review

|

(9 Publications)

MW 563.6 Da, Purity >98%. Potent, cell-permeable, O-GlcNAc transferase (OGT) inhibitor. Inhibits protein O-GlcNAcylation in several mammalian cell lines without qualitatively altering cell surface N- or O-linked glycans.

Key facts

CAS number

1681056-61-0

Purity

>98%

Form

Solid

form

Molecular weight

563.6 Da

Molecular formula

C<sub>2</sub><sub>8</sub>H<sub>2</sub><sub>5</sub>N<sub>3</sub>O<sub>6</sub>S<sub>2</sub>

PubChem

118634407

Nature

Synthetic

Solubility

DMSO ~20 mg/mL

Biochemical name

(R)-N-(furan-2-ylmethyl)-2-(2-methoxyphenyl)-2-(2-oxo-1,2-dihydroquinoline-6-sulfonamido)-N-(thiophen-2-ylmethyl)acetamide

Biological description

Potent, cell-permeable, O-GlcNAc transferase (OGT) inhibitor. Inhibits protein O-GlcNAcylation in several mammalian cell lines without qualitatively altering cell surface N- or O-linked glycans.

Canonical smiles

COC1=CC=CC=C1C(C(=O)N(CC2=CC=CO2)CC3=CC=CS3)NS(=O)(=O)C4=CC5=C(C=C4)NC(=O)C=C5

Isomeric smiles

COC1=CC=CC=C1[C@H](C(=O)N(CC2=CC=CO2)CC3=CC=CS3)NS(=O)(=O)C4=CC5=C(C=C4)NC(=O)C=C5

InChi

InChI=1S/C28H25N3O6S2/c1-36-25-9-3-2-8-23(25)27(28(33)31(17-20-6-4-14-37-20)18-21-7-5-15-38-21)30-39(34,35)22-11-12-24-19(16-22)10-13-26(32)29-24/h2-16,27,30H,17-18H2,1H3,(H,29,32)/t27-/m1/s1

InChiKey

IYIGLWQQAMROOF-HHHXNRCGSA-N

IUPAC Name

(2R)-N-(furan-2-ylmethyl)-2-(2-methoxyphenyl)-2-[(2-oxo-1H-quinolin-6-yl)sulfonylamino]-N-(thiophen-2-ylmethyl)acetamide

Product details

This product is manufactured by BioVision, an Abcam company and was previously called B1916 OSMI-1. B1916-5 is the same size as the 5 mg size of ab235455.

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store in the dark|Store under desiccating conditions

Product protocols

Publications (9)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 15:7430 PubMed39198412

2024

hnRNP R promotes O-GlcNAcylation of eIF4G and facilitates axonal protein synthesis.

Applications

Unspecified application

Species

Unspecified reactive species

Abdolhossein Zare,Saeede Salehi,Jakob Bader,Cornelius Schneider,Utz Fischer,Alexander Veh,Panagiota Arampatzi,Matthias Mann,Michael Briese,Michael Sendtner

Diabetologia 66:931-954 PubMed36759348

2023

Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Da Som Lee,Tae Hyeon An,Hyunmi Kim,Eunsun Jung,Gyeonghun Kim,Seung Yeon Oh,Jun Seok Kim,Hye Jin Chun,Jaeeun Jung,Eun-Woo Lee,Baek-Soo Han,Dai Hoon Han,Yong-Ho Lee,Tae-Su Han,Keun Hur,Chul-Ho Lee,Dae-Soo Kim,Won Kon Kim,Jun Won Park,Seung-Hoi Koo,Je Kyung Seong,Sang Chul Lee,Hail Kim,Kwang-Hee Bae,Kyoung-Jin Oh

The Journal of biological chemistry 298:102115 PubMed35690146

2022

Histone methyltransferase Dot1L recruits O-GlcNAc transferase to target chromatin sites to regulate histone O-GlcNAcylation.

Applications

Unspecified application

Species

Unspecified reactive species

Bo Xu,Can Zhang,Ao Jiang,Xianhong Zhang,Fenfei Liang,Xueqing Wang,Danni Li,Chenglong Liu,Xiaomei Liu,Jing Xia,Yang Li,Yirong Wang,Zelan Yang,Jia Chen,Yu Zhou,Liang Chen,Hui Sun

American journal of cancer research 12:1556-1576 PubMed35530290

2022

Differential effects of glucose and N-acetylglucosamine on genome instability.

Applications

Unspecified application

Species

Unspecified reactive species

Yuan-Sheng Hsu,Pei-Jung Wu,Yung-Ming Jeng,Chun-Mei Hu,Wen-Hwa Lee

BioFactors (Oxford, England) 47:992-1015 PubMed34418170

2021

O-GlcNAcylation drives calcium signaling toward osteoblast differentiation: A bioinformatics-oriented study.

Applications

Unspecified application

Species

Unspecified reactive species

Yao Weng,Ziyi Wang,Yoko Fukuhara,Airi Tanai,Mika Ikegame,Daisuke Yamada,Takeshi Takarada,Takashi Izawa,Satoru Hayano,Kaya Yoshida,Hiroshi Kamioka,Hirohiko Okamura

Nature communications 12:4980 PubMed34404792

2021

Spatiotemporally-resolved mapping of RNA binding proteins via functional proximity labeling reveals a mitochondrial mRNA anchor promoting stress recovery.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Qin,Samuel A Myers,Dominique K Carey,Steven A Carr,Alice Y Ting

Cell metabolism 33:598-614.e7 PubMed33592173

2021

A cold-stress-inducible PERK/OGT axis controls TOM70-assisted mitochondrial protein import and cristae formation.

Applications

Unspecified application

Species

Unspecified reactive species

Pedro Latorre-Muro,Katherine E O'Malley,Christopher F Bennett,Elizabeth A Perry,Eduardo Balsa,Clint D J Tavares,Mark Jedrychowski,Steven P Gygi,Pere Puigserver

Frontiers in physiology 11:1092 PubMed33192538

2020

OGT-Mediated KEAP1 Glycosylation Accelerates NRF2 Degradation Leading to High Phosphate-Induced Vascular Calcification in Chronic Kidney Disease.

Applications

Unspecified application

Species

Unspecified reactive species

Tian-Hua Xu,Yinke Du,Zitong Sheng,Yue Li,Xiaobo Qiu,Binyao Tian,Li Yao

Theranostics 10:7178-7192 PubMed32641986

2020

Inflammatory IFIT3 renders chemotherapy resistance by regulating post-translational modification of VDAC2 in pancreatic cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Zhefang Wang,Jie Qin,Jiangang Zhao,Jiahui Li,Dai Li,Marie Popp,Felix Popp,Hakan Alakus,Bo Kong,Qiongzhu Dong,Peter J Nelson,Yue Zhao,Christiane J Bruns
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com